𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative bioavailability of two commercial preparations of carbamazepine tablets

✍ Scribed by M. Anttila; P. Kahela; M. Panelius; T. Yrjänä; R. Tikkanen; R. Aaltonen


Publisher
Springer
Year
1979
Tongue
English
Weight
350 KB
Volume
15
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparative bioavailability of carbamaze
✍ M. Reunanen; E.H. Heinonen; L. Nyman; M. Anttila 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 425 KB

In order to compare the multiple-dose bioavailability of carbamazepine (CBZ) from 2 slow-release preparations, Neurotol slow and Tegretol Retard, a single-blind, randomized, cross-over study was carried out. 21 adult patients with epilepsy were enrolled in the study. At the end of both 2-week treatm

Comparative bioavailability of four comm
✍ Jeffrey D. Strum; John L. Colaizzi; James M. Jaffe; Perry C. Martineau; Rolland 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

A comparative bioavailability study was performed using four commercially available, chemically equivalent brands of quinidine sulfate tablets. Two 200-mg tablets were administered to 11 different subjects following a completely randomized crossover design. Serum levels, urinary excretion data, and

Comparative bioavailability and steady s
✍ Kamlesh M. Thakker; Surinder Mangat; William R. Garnett; René H. Levy; Gregory M 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

## Abstract The comparative bioavailability and steady state fluctuations resulting from the administration of Tegretol 200 mg commercial tablets and carbamazepine OROS controlled delivery tablets were investigated in 22 adult and 12 pediatric epileptic patients. Tegretol commercial tablets were do